Advertisement
News
Advertisement

Global Healthcare, Regulatory and Reimbursement Landscape Forecasts and Trends in UAE, Canada and Taiwan

Mon, 11/26/2012 - 1:55pm
Bio-Medicine.Org

FARMINGTON, Conn., Nov. 26, 2012 /PRNewswire-iReach/ -- The healthcare system in the United Arab Emirates is characterized by high public expenditure on implementation of healthcare policies and expanding private infrastructure to offer more sophisticated facilities. Taiwan's healthcare system is characterized by three positive trends: a growing elderly population, universal healthcare insurance, and a high degree of access to healthcare facilities. In Canada, government initiatives for the prevention and management of chronic diseases in addition to strong, efficient, and transparent guidelines that simplify the regulatory process differentiate the positive trends in the Canadian healthcare market.

(Photo: http://photos.prnewswire.com/prnh/20121126/CG18486)

Global Information Inc (GII) is pleased to present three market research reports covering the healthcare, regulatory and reimbursement market landscapes in the UAE, Canada, and Taiwan from our premium research partner, GlobalData.

Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates

The UAE is the second largest country in the Middle East in terms of capital invested in the pharmaceutical sector. Its pharmaceutical market was worth $1 billion in 2006 and is estimated to reach approximately $3.7 billion by 2020 at a Compound Annual Growth Rate (CAGR) of 9.8% (Kulkarni, 2010). The growing popularity of medical tourism is the main contributor to market growth, as well as factors such as the growing elderly population.

The medical device market in the UAE was worth approximately $541.1m in 2006 and is estimated to reach $979m by 2020 at a CAGR of 4.3%.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading